|
"hsu cc"的相关文件
显示项目 216-225 / 686 (共69页)
<< < 17 18 19 20 21 22 23 24 25 26 > >>
每页显示[10|25|50]项目
| 國家衛生研究院 |
2021-01-10 |
Dipeptidyl peptidase-4 inhibitors may accelerate cirrhosis decompensation in patients with diabetes and liver cirrhosis: A nationwide population-based cohort study in Taiwan
|
Yen, FS;Wei, JCC;Yip, HT;Hwu, CM;Hou, MC;Hsu, CC |
| 國家衛生研究院 |
2021-01 |
The performance and crisis of Taiwan Smokers' Helpline in 2019
|
Hsu, CC;Chen, JH;Chen, SW |
| 中山醫學大學 |
2021 |
Long-term outcomes of adding alpha-glucosidase inhibitors in insulin-treated patients with type 2 diabetes
|
Yen, FS; Wei, JCC; Lin, MC; Hsu, CC; Hwu, CM |
| 中山醫學大學 |
2021 |
Outcomes of second-line oral antidiabetic drugs in persons with young-onset type 2 diabetes
|
Yen, FS; Wei, JCC; Liu, JS; Hsu, CC; Hwu, CM |
| 中山醫學大學 |
2021 |
Thiazolidinedione Use in Individuals With Type 2 Diabetes and Chronic Obstructive Pulmonary Disease
|
Yen, FS; Wei, JCC; Yang, YC; Hsu, CC; Hwu, CM |
| 中山醫學大學 |
2021 |
TGR5 Expression Is Associated with Changes in the Heart and Urinary Bladder of Rats with Metabolic Syndrome
|
Hsu, CC; Cheng, KC; Li, YX; Hsu, PH; Cheng, JT; Niu, HS |
| 中山醫學大學 |
2021 |
Impacts of early insulin treatment vs glimepiride in diabetic patients with background metformin therapy A nationwide retrospective cohort study
|
Yen, FS; Hsu, CC; Su, YC; Wei, JCC; Hwu, CM |
| 中山醫學大學 |
2021 |
Dipeptidyl peptidase-4 inhibitors may accelerate cirrhosis decompensation in patients with diabetes and liver cirrhosis: a nationwide population-based cohort study in Taiwan
|
Yen, FS; Wei, JCC; Yip, HT; Hwu, CM; Hou, MC; Hsu, CC |
| 中山醫學大學 |
2021 |
Is insulin the preferred treatment in persons with type 2 diabetes and liver cirrhosis?
|
Yen, FS; Lai, JN; Wei, JCC; Chiu, LT; Hsu, CC; Hou, MC; Hwu, CM |
| 中山醫學大學 |
2021 |
Urate-lowering Therapy and Chronic Kidney Disease Development in Patients with Gout
|
Yen, FS; Wei, JCC; Chang, CL; Yang, CC; Hsu, CC; Hwu, CM |
显示项目 216-225 / 686 (共69页)
<< < 17 18 19 20 21 22 23 24 25 26 > >>
每页显示[10|25|50]项目
|
